Related Experiment Videos

An unusual alteration in c-myc in tissue from a primary breast carcinoma

J M Varley1, A M Wainwright, W J Brammar

  • 1ICI/University Joint Laboratory, University of Leicester, UK.

Oncogene
|January 1, 1987
PubMed

Insights

Researchers found a rearranged c-myc gene in aggressive breast cancer tissue. A deletion in exon 3 resulted in a truncated myc protein, potentially impacting cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The c-myc gene is a crucial proto-oncogene involved in cell growth and proliferation.
  • Aberrant c-myc expression is frequently observed in various human cancers, including breast carcinoma.
  • Understanding c-myc gene rearrangements is vital for elucidating cancer pathogenesis.

Observation:

  • Analysis of tumor DNA from a patient with aggressive breast carcinoma revealed a rearranged c-myc gene.
  • The rearrangement involved a deletion of approximately 5 kb within exon 3 of the c-myc gene.
  • This deletion disrupts the coding sequence, leading to a truncated myc protein.

Findings:

  • The specific breakpoint within exon 3 and the downstream sequence involved in the deletion were precisely identified.
  • Sequence analysis indicated a short region of homology at the breakpoint.
  • This homology suggests a potential mechanism of illegitimate recombination leading to the c-myc gene rearrangement.

Implications:

  • The truncated myc protein with an altered C-terminus may have altered functional properties, contributing to aggressive tumor behavior.
  • The identification of the recombination mechanism provides insights into genomic instability in cancer.
  • Further research into this specific c-myc alteration could reveal novel therapeutic targets for aggressive breast cancer.

Related Concept Videos